Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 3.500
-0.080 (-2.23%)
At close: Feb 24, 2026
Carvolix Company Description
Carvolix SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France.
It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm.
The company was formerly known as Affluent Medical SA and changed its name to Carvolix SA in February 2026.
Carvolix SA was founded in 2011 and is headquartered in Aix-en-Provence, France.
Carvolix SA
| Country | France |
| Founded | 2011 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 76 |
| CEO | Sebastien Ladet |
Contact Details
Address: 320, avenue ArchimEde Aix-en-Provence, 13100 France | |
| Phone | 33 4 42 95 12 20 |
| Website | carvolix.eu |
Stock Details
| Ticker Symbol | CVX |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0013333077 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Sebastien Ladet | Chief Executive Officer |
| Christophe de Vregille | Chief Financial Officer |